The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Diagnosis of bone metastasis in patients with lung cancer using urinary and serum collagen type I telopeptide (NTx).
H. Okada
No relevant relationships to disclose
M. Tamiya
No relevant relationships to disclose
S. Tokunaga
No relevant relationships to disclose
H. Daga
No relevant relationships to disclose
K. Taira
No relevant relationships to disclose
S. Kobayashi
No relevant relationships to disclose
A. Tanaka
No relevant relationships to disclose
N. Miyamoto
No relevant relationships to disclose
M. Hattori
No relevant relationships to disclose
M. Kobayashi
No relevant relationships to disclose
N. Okamoto
No relevant relationships to disclose
S. Sasada
No relevant relationships to disclose
H. Suzuki
No relevant relationships to disclose
N. Morishita
No relevant relationships to disclose
Y. Matsuura
No relevant relationships to disclose
T. Hirashima
No relevant relationships to disclose
K. Takeda
No relevant relationships to disclose